市场调查报告书
商品编码
1274235
心臟闭合装置全球市场研究报告——2023-2030 年行业分析、规模、份额、增长、趋势和预测Global Heart Closure Devices Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030 |
全球对心臟闭合装置市场的需求将从 2022 年的 61.2 亿美元增长到 2030 年的近 230.4 亿美元,在 2023-2030 年研究期间的复合年增长率为 18.02% 据估计,
心臟闭合装置是一种用于闭合心臟孔洞的医疗器械,例如卵圆孔 (PFO) 或房间隔缺损 (ASD)。 心臟闭合装置用于称为经导管闭合的微创手术以闭合孔。 心臟闭合装置有多种类型,包括贴片、塞子和封堵器。 用心臟闭合装置闭合心臟孔通常是安全的。 与心臟直视手术相比,它的成功率高,恢復时间短,并发症风险更低。
先天性心脏病患病率的增加是心臟闭合装置市场的主要驱动力。 随着人口的增长和老龄化,患有先天性心脏病的人数预计会增加,从而推动对心臟闭合装置的需求。 此外,越来越多地采用微创手术也推动了心臟闭合装置市场的增长。 此外,新的和更先进的心臟闭合装置的开发正在推动市场增长。 此外,人们越来越意识到心臟闭合装置的优势,例如降低并发症的风险和更快的恢復,预计将增加对这些装置的需求。 然而,这些设备的高成本可能会限制市场增长。
研究报告涵盖波特五力模型、市场吸引力分析、价值链分析等。 这些工具可帮助您清楚地了解您的行业结构并评估您在全球范围内的竞争吸引力。 此外,这些工具还对全球心臟闭合装置市场的每个细分市场进行了全面评估。 心臟闭合装置行业的发展和趋势为这项研究提供了一个整体方法。
本部分按国家和地区提供详细的细分数据,以帮助您确定目标受众以及您的产品和服务的未来商机。
本节涵盖区域展望,重点介绍北美、欧洲、亚太地区、拉丁美洲、中东和非洲心臟闭合装置市场当前和未来的需求。 此外,我们还关注所有主要地区各个应用领域的需求、估计和预测。
该研究报告还涵盖了市场主要参与者的综合概况和全球竞争格局的详细视图。 心臟闭合装置市场的主要参与者是雅培实验室、W. L. Gore &Associates Inc、波士顿科学公司、Occlutech、Heartstitch、SMT、Cardia, Inc.、Lifetech Scientific Corp、乐普医疗技术(北京)有限公司、AtriCure Inc This部分概述了竞争格局,包括各种战略发展,例如主要併购、未来能力、合作伙伴关係、财务概览、合作、新产品开发和新产品发布。
注意:公司简介中的财务细节和近期发展基于可用信息,可能不包括私营公司。
The global demand for Heart Closure Devices Market is presumed to reach the market size of nearly USD 23.04 BN by 2030 from USD 6.12 BN in 2022 with a CAGR of 18.02% under the study period 2023 - 2030.
Heart closure devices are medical devices used to close a hole in the heart, such as a patent foramen ovale (PFO) or an atrial septal defect (ASD). Heart closure devices are used in a minimally invasive procedure called transcatheter closure to seal the hole. There are several types of heart closure devices, including patches, plugs, and occluders. The procedure to close a hole in the heart with a heart closure device is generally safe. It has a high success rate, shorter recovery time and a lower risk of complications than open heart surgery.
The increasing prevalence of congenital heart defects, which are present at birth, is a major driver of the heart closure device market. As the population grows and ages, the number of people with congenital heart defects is expected to increase, driving demand for heart closure devices. Moreover, the increasing adoption of minimally invasive procedures drives growth in the heart closure device market. Also, developing new, more advanced heart closure devices is driving growth in the market. Furthermore, with the growing awareness of the benefits of heart closure devices, such as their low risk of complications and quick recovery time, demand for these devices is expected to increase. However, the high cost of these devices may limit the market growth.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of heart closure devices. The growth and trends of heart closure devices industry provide a holistic approach to this study.
This section of the heart closure devices market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
This section covers the regional outlook, which accentuates current and future demand for the Heart Closure Devices market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the heart closure devices market include Abbott Laboratories, W. L. Gore & Associates Inc, Boston Scientific Corp., Occlutech, Heartstitch, SMT, Cardia, Inc., Lifetech Scientific Corp., Lepu Medical Technology (Beijing)Co. Ltd., AtriCure Inc.. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.